Jubilant Life Sciences reports marginal fall in Q3 consolidated net profit

07 Feb 2017 Evaluate

Jubilant Life Sciences has reported results for third quarter ended December 31, 2016.  

The company has reported 71.47% fall in its net profit at Rs 8.26 crore for the quarter under review as compared to Rs 28.95 crore for the same quarter in the previous year. Total income of the company decreased by 4.82% at Rs 651.22 crore for the quarter under review as compared Rs 684.20 crore for the corresponding quarter previous year.       

On the consolidated basis, the company has reported marginal fall of 2.63%  in its net profit after tax, minority interest and share of profit / (Loss) of associates and Joint Ventures at Rs 119.78 crore for the quarter ended December 31, 2016, as compared to Rs 123.01 crore for the same quarter in the previous year. However, total income of the company increased by 6.65% at Rs 1496.76 crore for the quarter under review as compared Rs 1403.44 crore for the corresponding quarter previous year.   

 

Jubilant Pharmova Share Price

1092.95 33.15 (3.13%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×